Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls

European Journal of Cancer

Volumn 46, Issue 3, 2010, Pages 606-615

  Dunberger, Gail ^a   Lind, Helena ^a   Steineck, Gunnar ^a,b   Waldenström, Ann Charlotte ^c   Nyberg, Tommy ^a   al Abany, Massoud ^a,d   Nyberg, Ullakarin ^a   Åvall Lundqvist, Elisabeth ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Faecal incontinence; Gastrointestinal symptom; Pelvic radiotherapy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATTRIBUTABLE RISK; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVOR; COHORT ANALYSIS; CONTROLLED STUDY; DEFECATION URGENCY; DEMOGRAPHY; FECES INCONTINENCE; FEMALE; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC CANCER; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RESIDENTIAL AREA; SELF REPORT; SOCIAL STATUS;

ADULT; AGED; COMBINED MODALITY THERAPY; EPIDEMIOLOGIC METHODS; FECAL INCONTINENCE; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY; SURVIVORS; SWEDEN;

EID: 75149137365     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.10.023     Document Type: Article

References (25)

1. Gerda Engholm, Jacques Ferlay, Niels Christensen, et al. NORDCAN: cancer incidence, mortality and prevalence in the Nordic countries, Version 3.4. Association of Nordic Cancer Registries. Danish Cancer Society. ; 2009.
2. Creutzberg C.L., van Putten W.L., Koper P.C., et al. The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys 51 (2001) 1246-1255
3. Geinitz H., Zimmermann F.B., Thamm R., et al. Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer. Radiother Oncol 79 (2006) 341-347
4. Haddock M.G., Sloan J.A., Bollinger J.W., et al. Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase III North Central Cancer Treatment Group clinical trial. J Clin Oncol 25 (2007) 1255-1259
5. Petersen S., Jongen J., Petersen C., and Sailer M. Radiation-induced sequelae affecting the continence organ: incidence, pathogenesis, and treatment. Dis Colon Rectum 50 (2007) 1466-1474
6. Yeoh E., Sun W.M., Russo A., Ibanez L., and Horowitz M. A retrospective study of the effects of pelvic irradiation for gynecological cancer on anorectal function. Int J Radiat Oncol Biol Phys 35 (1996) 1003-1010
7. Rubin P., Constine L.S., Fajardo L.F., Phillips T.L., Wasserman T.H., and RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31 (1995) 1041-1042
8. Mornex F., Pavy J.J., Denekamp J., and Bolla M. Scoring system of late effects of radiations on normal tissues: the SOMA-LENT scale. Cancer Radiother 1 (1997) 622-668
9. Pavy J.J., Denekamp J., Letschert J., et al., EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35 (1995) 11-15
10. Pavy J.J., Denekamp J., Letschert J., et al., EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys 31 (1995) 1043-1047
11. Chassagne D., Sismondi P., Horiot J.C., et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 26 (1993) 195-202
12. Bergmark K., Åvall-Lundqvist E., Dickman P.W., Henningsohn L., and Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. New Engl J Med 340 (1999) 1383-1389
13. Henningsohn L., Wijkström H., Dickman P.W., Bergmark K., and Steineck G. Distressful symptoms after radical cystectomy with urinary diversion for urinary bladder cancer: a Swedish population-based study. Eur Urol 40 (2001) 151-162
14. Kreicbergs U., Valdimarsdottir U., Onelöv E., Henter J.I., and Steineck G. Talking about death with children who have severe malignant disease. New Engl J Med 351 (2004) 1175-1186
15. Steineck G., Helgesen F., Adolfsson J., et al. Quality of life after radical prostatectomy or watchful waiting. New Engl J Med 347 (2002) 790-796
16. Steineck G., Hunt H., and Adolfsson J. A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods. Acta Oncol 45 (2006) 421-429
17. Nout R.A., Putter H., Jurgenliemk-Schulz I.M., et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol 27 (2009) 3547-3556
18. Klee M., Thranov I., and Machin Prof D. The patients' perspective on physical symptoms after radiotherapy for cervical cancer. Gynecol Oncol 76 (2000) 14-23
19. Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol 8 (2007) 1007-1017
20. Olopade F.A., Norman A., Blake P., et al. A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy. Br J Cancer 92 (2005) 1663-1670
21. Landefeld C.S., Bowers B.J., Feld A.D., et al. National Institutes of Health State-of-the-Science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med 148 6 (2008) 449-458
22. al-Abany M., Helgason A.R., Cronqvist A.K., et al. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int J Radiat Oncol Biol Phys 61 (2005) 1035-1044
23. Fokdal L., Honore H., Hoyer M., and von der Maase H. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother Oncol 74 (2005) 203-210
24. Vordermark D., Schwab M., Ness-Dourdoumas R., et al. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol 69 (2003) 209-214
25. Andreyev H.J., Vlavianos P., Blake P., et al. Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?. Int J Radiat Oncol Biol Phys 62 (2005) 1464-1471